Evidence map›Paper›PMID 20713583›Full record

SynthesisBMJ (Clinical research ed.)2010

Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.

L J Middleton, R Champaneria, J P Daniels, S Bhattacharya, K G Cooper, N H Hilken, P O'Donovan, M Gannon, R Gray, K S Khan and 24 more

Open access · hybridAbstract readEvaluation StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 11 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 11 syntheses or guidelines pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.The Cochrane database of systematic reviews · 2020
    Pooled it
  4. Endometrial resection and ablation techniques for heavy menstrual bleeding.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Pooled it
  6. Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Menorrhagia.BMJ clinical evidence · 2012
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Analysis of Non-responders to LNG-IUS in Cases of Heavy Menstrual Bleeding.Journal of obstetrics and gynaecology of India · 2026
    Article
  16. Review
  17. Intersection of menstrual and menopausal health with mental health: implications for general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024
    Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 6 institutions in 2 countries.

L J MiddletonBirmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT. l.j.middleton@bham.ac.uk
R Champaneria
J P Daniels
S Bhattacharya
K G Cooper
N H Hilken
P O'Donovan
M Gannon
R Gray
K S Khan
International Heavy Menstrual Bleeding Individual Patient Data Meta-analysis Collaborative Group
J Abbott
J Barrington
S Bhattacharya
M Y Bongers
J-L Brun
R Busfield
M Sowter
T J Clark
J Cooper
K G Cooper
S L Corson
K Dickersin
N Dwyer
M Gannon
J Hawe
R Hurskainen
W R Meyer
H O'Connor
S Pinion
A M Sambrook
W H Tam
I A A van Zon-Rabelink
E Zupi
Cancer Research UK Clinical Trials Unit · GBUniversity of Birmingham · GBAberdeen Maternity Hospital · GBAberdeen Royal Infirmary · GBMidland Regional Hospital Mullingar · IEUniversity of Bradford · GB

Funding

Department of Health 05/45/02Medical Research Council MC_U137686861
6 · The paper itself

Abstract

objectiveTo evaluate the relative effectiveness of hysterectomy, endometrial destruction (both "first generation" hysteroscopic and "second generation" non-hysteroscopic techniques), and the levonorgestrel releasing intrauterine system (Mirena) in the treatment of heavy menstrual bleeding.

designMeta-analysis of data from individual patients, with direct and indirect comparisons made on the primary outcome measure of patients' dissatisfaction. DATA SOURCES: Data were sought from the 30 randomised controlled trials identified after a comprehensive search of the Cochrane Library, Medline, Embase, and CINAHL databases, reference lists, and contact with experts. Raw data were available from 2814 women randomised into 17 trials (seven trials including 1359 women for first v second generation endometrial destruction; six trials including 1042 women for hysterectomy v first generation endometrial destruction; one trial including 236 women for hysterectomy v Mirena; three trials including 177 women for second generation endometrial destruction v Mirena). Eligibility criteria for selecting studies Randomised controlled trials comparing hysterectomy, first and second generation endometrial destruction, and Mirena for women with heavy menstrual bleeding unresponsive to other medical treatment.

resultsAt around 12 months, more women were dissatisfied with outcome with first generation hysteroscopic techniques than with hysterectomy (13% v 5%; odds ratio 2.46, 95% confidence interval 1.54 to 3.9, P<0.001), but hospital stay (weighted mean difference 3.0 days, 2.9 to 3.1 days, P<0.001) and time to resumption of normal activities (5.2 days, 4.7 to 5.7 days, P<0.001) were longer for hysterectomy. Unsatisfactory outcomes were comparable with first and second generation techniques (odds ratio 1.2, 0.9 to 1.6, P=0.2), although second generation techniques were quicker (weighted mean difference 14.5 minutes, 13.7 to 15.3 minutes, P<0.001) and women recovered sooner (0.48 days, 0.20 to 0.75 days, P<0.001), with fewer procedural complications. Indirect comparison suggested more unsatisfactory outcomes with second generation techniques than with hysterectomy (11% v 5%; odds ratio 2.3, 1.3 to 4.2, P=0.006). Similar estimates were seen when Mirena was indirectly compared with hysterectomy (17% v 5%; odds ratio 2.2, 0.9 to 5.3, P=0.07), although this comparison lacked power because of the limited amount of data available for analysis.

conclusionsMore women are dissatisfied after endometrial destruction than after hysterectomy. Dissatisfaction rates are low after all treatments, and hysterectomy is associated with increased length of stay in hospital and a longer recovery period. Definitive evidence on effectiveness of Mirena compared with more invasive procedures is lacking.

Indexed as

HysterectomyIntrauterine Devices, MedicatedAdultContraceptive Agents, FemaleEndometriumFemaleHumansLength of StayLevonorgestrelMenorrhagiaPatient SatisfactionRandomized Controlled Trials as TopicRegression AnalysisTreatment OutcomeContraceptive Agents, FemaleLevonorgestrel

Identifiers

PMID20713583
PMCPMC2922496
OpenAlexW2002216387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.